Okyo Pharma Ltd. (OKYO)
NASDAQ · Healthcare
Okyo Pharma Ltd. Income Statement 2020–2025
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -7.1M | -15.7M | -13.2M | -4.6M | -3.4M | -1.5M |
| EBITDA | -7.1M | -15.7M | -13.2M | -4.6M | -3.4M | -1.5M |
| Net Income | -4.7M | -16.8M | -13.3M | -4.0M | -3.4M | -1.5M |
| Per Share Data | ||||||
| EPS (diluted) | $-0.12 | $-0.57 | $-0.61 | $-0.36 | $-0.32 | $-0.00 |
| Shares Outstanding (dil.) | 39M | 29M | 22M | 11M | 8M | 473M |
Okyo Pharma Ltd. Income Statement — FAQ
Okyo Pharma Ltd. (OKYO) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OKYO's income statement history?
The chart and table above show Okyo Pharma Ltd.'s income statement by year and by quarter, including the growth rate.